Revival: Your Life or Mine (2003): How Geoethics can Resolve the Conflict Between Public and Private Interests in Xenotransplantation (Routledge Revivals)
Revival: Your Life or Mine (2003): How Geoethics can Resolve the Conflict Between Public and Private Interests in Xenotransplantation (Routledge Revivals)
Revival: Your Life or Mine (2003): How Geoethics can Resolve the Conflict Between Public and Private Interests in Xenotransplantation (Routledge Revivals) - Martine Rothblatt
Physical Book
£ 29.69
£ 32.99
You save: £ 3.30
10% discount
Free UK Delivery
Choose the list to add your product or create one New List
It will be shipped from our warehouse between Tuesday, July 09 and Friday, July 12.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Revival: Your Life or Mine (2003): How Geoethics can Resolve the Conflict Between Public and Private Interests in Xenotransplantation (Routledge Revivals)
Martine Rothblatt
Synopsis "Revival: Your Life or Mine (2003): How Geoethics can Resolve the Conflict Between Public and Private Interests in Xenotransplantation (Routledge Revivals)"
This title was first published in 2003. Xenotransplantation - the transplantation of animal organs into humans - poses a fascinating moral dilemma. Should this ability to extend the lives of millions of older people be permitted given that it might trigger a new pandemic similar to AIDS? This study examines the moral dilemma from a combination of humanistic, legalistic, bioethical, economical and technological perspectives. The first part of the book demonstrates that xenografts are the only realistic near-term technological answer to the organ shortage problem. The balance of the book is devoted to assessing whether doctrines such as the 'right to health care' trump the moral and ethical conundrums posed by xenotransplantation. The book concludes with a 'geoethical' solution that proposes authorization of xenotransplantation subject to the prior implementation of a new international organization for epidemiology and basic health care. It also suggests that the costs of operating such an organization could be covered by a global tax on xenografts.